Leadership transition builds on AdhereTech’s expanding adoption of real-time medication adherence smart devices, ahead of SCOPE 2026.

AdhereTech, a leader in real-time medication adherence smart devices, today announced the appointment of Jeremy Gilbert as chief executive officer. Gilbert, who previously served as AdhereTech’s chief product development officer, brings more than 20 years of experience building and scaling digital health, life sciences, and enterprise technology solutions that improve patient outcomes and protect critical research and commercial investments.

The appointment reflects AdhereTech’s investment in its next phase of growth as the industry places increasing emphasis on medication adherence as a determinant of both clinical trial integrity and real-world treatment success. As CEO, Gilbert will focus on scaling adoption of AdhereTech’s smart devices across clinical development and commercial patient support programs while continuing to advance the company’s product and technology roadmap.

“Medication non-adherence quietly undermines trial outcomes and patient care, often without being detected until late in a study or treatment journey,” said Gilbert. “AdhereTech was built to prevent missed doses before they happen and to make adherence measurable, actionable, and sustainable. Our smart devices embed intelligence directly into the medication experience, helping sponsors and brands protect outcomes while giving patients a simpler, more supportive way to stay on therapy.”

AdhereTech Smart Devices Improve Medication Adherence

AdhereTech’s smart devices are designed to prevent missed doses and make medication adherence measurable and actionable. Each device combines automated, on-device reminders with real-time cellular connectivity, integrating seamlessly into patients’ daily routines without requiring apps, Wi-Fi, or setup. Lights, chimes, and an LED display alert patients at the appropriate time, while automated monitoring ensures that study or care teams are notified only when intervention is needed. Device settings can be updated remotely via AdhereTech’s software portal, enabling rapid adjustments for any clinical or commercial workflow. As the only over-cap solution on the market, one device supports a patient throughout a study or program, reducing operational burden and supporting an environmentally conscious approach.

Enhancing Compliance in Clinical Trials

In clinical research, AdhereTech smart devices help sponsors protect study outcomes by improving protocol compliance and generating objective adherence data—without requiring changes to patient behavior or site workflows. More than 50 sponsors have deployed the devices across multiple disease areas, adding no complexity to patients’ existing pill routines and triggering reminders only when needed. The result is reduced patient and site burden alongside actionable, real-time insights. Remote management, automated reminders, and exception-based alerts allow study teams to focus on patients who need support, helping protect primary and secondary endpoints and optimize trial results.

Driving Persistence in Commercial Programs

In commercial patient support programs, the same low-burden smart devices improve persistence and the overall treatment experience. Top global pharmaceutical companies have used them to encourage early adoption, daily habit formation, and long-term adherence—without adding complexity for patients or providers. Across tens of thousands of patients, AdhereTech smart devices have driven measurable improvements, including an average 118 percent increase in persistence and multiple additional prescription fills within the first 12 months, while delivering insights that help brands better support patients.

AdhereTech at SCOPE 2026

AdhereTech will showcase its real-time medication adherence smart devices at the SCOPE Summit, February 2–5, 2026, at Rosen Shingle Creek in Orlando, Florida. Attendees can visit booth #1533 to see how AdhereTech’s smart devices support protocol compliance without adding burden for patients or sites.

About AdhereTech

AdhereTech is a digital health company that develops smart devices to improve medication adherence for patients, healthcare providers, and sponsors. Its real-time adherence platform combines automated, on-device reminders with data-driven insights, supporting better clinical trial outcomes and commercial patient programs. For more information, visit www.adheretech.com or follow us on LinkedIn https://www.linkedin.com/company/adheretech/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260127294118/en/